Yep. There is very very high probability of 2x2 receiving green light given it set a threshold for efficacy (versus other dose outcomes in interim read out of stage 1)
Rather FDA will focus on ongoing safety monitoring protocols for stage 2.
- Forums
- ASX - By Stock
- PAR
- Ann: PAR to present at NWR Healthcare Conference
Ann: PAR to present at NWR Healthcare Conference, page-20
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.55M |
Open | High | Low | Value | Volume |
21.0¢ | 22.0¢ | 20.5¢ | $222.5K | 1.035M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 77810 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 23000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 77810 | 0.210 |
4 | 57926 | 0.205 |
9 | 245349 | 0.200 |
10 | 308635 | 0.195 |
16 | 208884 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 23000 | 2 |
0.225 | 72722 | 5 |
0.230 | 31334 | 3 |
0.235 | 45854 | 2 |
0.240 | 65386 | 4 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |